Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMoneycontrol ResearchPharma: Trump’s executive orders may possibly provide better market access opportunities

    Pharma: Trump’s executive orders may possibly provide better market access opportunities

    Indian drugmakers such as Cipla, Cadila, Lupin, Dr Reddy’s, Sun Pharma and a few small-sized pharma companies such as Laurus Labs may benefit from a likely revamp of US medicare

    Anubhav Sahu
    July 27, 2020 / 20:06 IST
    Bharat Immunologicals & Biologicals Corporation | In the last four months, the stock price has risen 444 percent to Rs 31.34 per share from Rs 5.76 per share on March 27, 2020.
    • PRO Panorama

      Moneycontrol Pro Panorama | Fintechs are quietly winning the retail loan race

      Nov 19, 2025 / 03:38 PM IST

      Moneycontrol's Pro Panorama November 19 edition: A silent shift is underway in India’s credit landscape, with fintechs pulling a...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | Samvat 2082: The Will to Rise

      Oct 18, 2025 / 10:00 AM IST

      After a turbulent Samvat 2081, the markets step into the new year not with fireworks but with quiet resolve and the will to rise

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More